These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 5047088)

  • 21. Measles and measles vaccine in pre-industrial countries.
    Morley DC
    Mod Trends Med Virol; 1967; 1(0):141-61. PubMed ID: 4950644
    [No Abstract]   [Full Text] [Related]  

  • 22. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
    Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
    [No Abstract]   [Full Text] [Related]  

  • 23. [Age-dependence of measles immunization failures].
    Giesecke H; Brendel P; Schmidt J; Schlenk B
    Z Gesamte Hyg; 1980; 26(10):764-67. PubMed ID: 7467503
    [No Abstract]   [Full Text] [Related]  

  • 24. [Measles vaccination in Norway].
    Tidsskr Nor Laegeforen; 1976 Oct; 96(29):1533-5. PubMed ID: 982382
    [No Abstract]   [Full Text] [Related]  

  • 25. [Repercussions of vaccination against measles].
    Guerrero EV; Calderón C; Velázquez Franco E
    Salud Publica Mex; 1974; 16(5):707-20. PubMed ID: 4456647
    [No Abstract]   [Full Text] [Related]  

  • 26. Complicated measles after killed vaccine.
    Can Med Assoc J; 1970 Oct; 103(7):766-7. PubMed ID: 5506115
    [No Abstract]   [Full Text] [Related]  

  • 27. [Eradication of measles. Strategies in the Autonomous Community of Catalonia].
    Salleras Sanmartí L; Domínguez García A; Batalla Clavell J; Coll RP
    Rev Esp Salud Publica; 1999; 73(5):619-27. PubMed ID: 10650754
    [No Abstract]   [Full Text] [Related]  

  • 28. [Vaccination against measles].
    Ek E
    Tidsskr Nor Laegeforen; 1971 Jan; 91(2):135-7. PubMed ID: 5539605
    [No Abstract]   [Full Text] [Related]  

  • 29. [The eradication of measles by general vaccination is beneficial and feasible].
    Rey M
    Ann Pediatr (Paris); 1984 Jun; 31(6):483-7. PubMed ID: 6380378
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preventive measles vaccine].
    Gerike E; Rasch G
    Z Arztl Fortbild (Jena); 1990; 84(8):369-71. PubMed ID: 2378118
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the gravity of complications of measles after the epidemic that occurred in the winter of 1968-1969, in patients hospitalized in the infectious disease clinic of Cluj].
    Josan R; Suciu O; Iepureanu A; Marina M
    Pediatria (Bucur); 1970; 19(1):41-50. PubMed ID: 5419929
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 33. Measles and measles vaccination in isolated Amerindian tribes. II. The 1978/79 Xingu epidemic.
    Baruzzi RG; Abdala N; Black FL
    Trop Geogr Med; 1982 Mar; 34(1):7-12. PubMed ID: 7080192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Indications and contraindications for the measles vaccination of children with an aggravated neurological anamnesis].
    Kossova ET; Dadiomova MA; Lakotkina EA; Ryzhova TP
    Tr Inst Im Pastera; 1979; 53():40-3. PubMed ID: 262710
    [No Abstract]   [Full Text] [Related]  

  • 35. Measles vaccination and risk of SSPE.
    Agarwal RK
    Indian Pediatr; 1999 Mar; 36(3):317. PubMed ID: 10713848
    [No Abstract]   [Full Text] [Related]  

  • 36. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
    Ikić DM
    Rev Infect Dis; 1983; 5(3):558-63. PubMed ID: 6879014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract]   [Full Text] [Related]  

  • 38. Priority for measles vaccine.
    John TJ; Devarajan LV
    Indian Pediatr; 1973 Feb; 10(2):57-8. PubMed ID: 4719646
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of the use of the Leningrad-4 live measles vaccine during increasing measles morbidity].
    Revenok ND; Smorodintsev AA
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():361-71. PubMed ID: 5860954
    [No Abstract]   [Full Text] [Related]  

  • 40. Progress toward measles elimination in Germany.
    Hellenbrand W; Siedler A; Tischer A; Meyer C; Reiter S; Rasch G; Teichmann D; Santibanez S; Altmann D; Claus H; Kramer M
    J Infect Dis; 2003 May; 187 Suppl 1():S208-16. PubMed ID: 12721915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.